Published in Psychopharmacology (Berl) on February 05, 2005
A unified framework for addiction: vulnerabilities in the decision process. Behav Brain Sci (2008) 2.83
Cognitive function during early abstinence from opioid dependence: a comparison to age, gender, and verbal intelligence matched controls. BMC Psychiatry (2006) 0.96
Withdrawal from acute morphine dependence is accompanied by increased anxiety-like behavior in the elevated plus maze. Pharmacol Biochem Behav (2008) 0.95
Distinct profiles of anxiety and dysphoria during spontaneous withdrawal from acute morphine exposure. Neuropsychopharmacology (2009) 0.92
Effects of the NMDA receptor antagonist memantine on the expression and development of acute opiate dependence as assessed by withdrawal-potentiated startle and hyperalgesia. Psychopharmacology (Berl) (2007) 0.88
Potentiated startle as a measure of the negative affective consequences of repeated exposure to nicotine in rats. Psychopharmacology (Berl) (2009) 0.87
Episodic withdrawal promotes psychomotor sensitization to morphine. Neuropsychopharmacology (2010) 0.87
The α3β4* nicotinic ACh receptor subtype mediates physical dependence to morphine: mouse and human studies. Br J Pharmacol (2014) 0.86
Rapid neuroadaptation in the nucleus accumbens and bed nucleus of the stria terminalis mediates suppression of operant responding during withdrawal from acute opioid dependence. Neuroscience (2006) 0.83
Intracranial self-stimulation reward thresholds during morphine withdrawal in rats bred for high (HiS) and low (LoS) saccharin intake. Brain Res (2015) 0.82
Mecamylamine elicits withdrawal-like signs in rats following a single dose of nicotine. Psychopharmacology (Berl) (2012) 0.82
Protracted manifestations of acute dependence after a single morphine exposure. Psychopharmacology (Berl) (2011) 0.79
Delay discounting of oral morphine and sweetened juice rewards in dependent and non-dependent rats. Psychopharmacology (Berl) (2014) 0.78
Relative potency of the opioid antagonists naloxone and 6-alpha-naloxol to precipitate withdrawal from acute morphine dependence varies with time post-antagonist. Pharmacol Biochem Behav (2008) 0.77
Acute delta- and kappa-opioid agonist pretreatment potentiates opioid antagonist-induced suppression of water consumption. Brain Res Bull (2008) 0.75
A Two-Day Continuous Nicotine Infusion Is Sufficient to Demonstrate Nicotine Withdrawal in Rats as Measured Using Intracranial Self-Stimulation. PLoS One (2015) 0.75
Effects of repeated morphine on ultrasonic vocalizations in adult rats: increased 50-kHz call rate and altered subtype profile. Psychopharmacology (Berl) (2016) 0.75
The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev (1993) 19.60
Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J Physiol (1973) 14.99
Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology (2001) 9.25
Drug abuse: hedonic homeostatic dysregulation. Science (1997) 8.22
Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature (1996) 7.15
Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature (2001) 5.65
Addiction and the brain: the neurobiology of compulsion and its persistence. Nat Rev Neurosci (2001) 4.58
Molecular and cellular basis of addiction. Science (1997) 3.57
Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev (2001) 3.45
Long-term depression in the nucleus accumbens: a neural correlate of behavioral sensitization to cocaine. Nat Neurosci (2001) 3.41
Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice. J Pharmacol Exp Ther (1991) 2.96
Neural organization of the defensive behavior system responsible for fear. Psychon Bull Rev (1994) 2.79
New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: the striatopallidal, amygdaloid, and corticopetal components of substantia innominata. Neuroscience (1988) 2.50
Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion. Nature (2000) 2.38
Persistent protein kinase activity underlying long-term potentiation. Nature (1988) 2.07
Modification of morphine withdrawal by drugs interacting with humoral mechanisms: some contradictions and their interpretation. Nature (1972) 2.04
Dynamics of drug dependence. Implications of a conditioning theory for research and treatment. Arch Gen Psychiatry (1973) 2.03
Molecular neurobiology of addiction. Am J Addict (2001) 1.97
Bidirectional synaptic plasticity: from theory to reality. Philos Trans R Soc Lond B Biol Sci (2003) 1.74
Pharmacology of opioids. Pharmacol Rev (1983) 1.62
Conditioned fear and startle magnitude: effects of different footshock or backshock intensities used in training. J Exp Psychol Anim Behav Process (1978) 1.60
Ethoexperimental approaches to the biology of emotion. Annu Rev Psychol (1988) 1.60
Naloxone-precipitated withdrawal jumping in 11 inbred mouse strains: evidence for common genetic mechanisms in acute and chronic morphine physical dependence. Neuroscience (2002) 1.47
Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats. Psychopharmacologia (1973) 1.46
The role of the striatopallidal and extended amygdala systems in drug addiction. Ann N Y Acad Sci (1999) 1.44
An antisense oligodeoxynucleotide to the delta opioid receptor (DOR-1) inhibits morphine tolerance and acute dependence in mice. Brain Res Bull (1996) 1.42
Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal. Behav Pharmacol (1995) 1.36
Relative sensitivity to naloxone of multiple indices of opiate withdrawal: a quantitative dose-response analysis. J Pharmacol Exp Ther (1994) 1.35
Neural systems underlying opiate addiction. J Neurosci (2002) 1.33
Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J Pharmacol Exp Ther (1992) 1.29
Opposite modulation of opiate withdrawal behaviors on microinfusion of a protein kinase A inhibitor versus activator into the locus coeruleus or periaqueductal gray. J Neurosci (1997) 1.28
Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience (1990) 1.28
Under siege: The brain on opiates. Neuron (1996) 1.26
Tolerance to opioid narcotics: time course and reversibility of physical dependence in mice. Nature (1971) 1.24
Evidence that the aversive effects of opioid antagonists and kappa-agonists are centrally mediated. Psychopharmacology (Berl) (1989) 1.23
Participation of noradrenergic pathways in the expression of opiate withdrawal: biochemical and pharmacological evidence. Neurosci Biobehav Rev (1997) 1.21
Constitutive mu opioid receptor activation as a regulatory mechanism underlying narcotic tolerance and dependence. Life Sci (1994) 1.20
The delta agonists DPDPE and deltorphin II recruit predominantly mu receptors to produce thermal analgesia: a parallel study of mu, delta and combinatorial opioid receptor knockout mice. Eur J Neurosci (2004) 1.19
Direct dependence studies in rats with agents selective for different types of opioid receptor. J Pharmacol Exp Ther (1988) 1.17
Conditioned narcotic withdrawal in humans. Science (1977) 1.16
Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal. Psychopharmacology (Berl) (2003) 1.15
Opiate withdrawal-induced fos immunoreactivity in the rat extended amygdala parallels the development of conditioned place aversion. Neuropsychopharmacology (2001) 1.13
Toward a molecular explanation for long-term potentiation. Learn Mem (1999) 1.09
Microinjections of an opiate receptor antagonist into the bed nucleus of the stria terminalis suppress heroin self-administration in dependent rats. Brain Res (2000) 1.08
Long-lasting increased pain sensitivity in rat following exposure to heroin for the first time. Eur J Neurosci (1998) 1.07
Anxiogenic-like effects of spontaneous and naloxone-precipitated opiate withdrawal in the elevated plus-maze. Pharmacol Biochem Behav (1998) 1.07
Role of corticotropin-releasing hormone in the amygdala and bed nucleus of the stria terminalis in the behavioral, pain modulatory, and endocrine consequences of opiate withdrawal. Neuroscience (2002) 1.07
Sex-related differences in morphine's antinociceptive activity: relationship to serum and brain morphine concentrations. J Pharmacol Exp Ther (1997) 1.06
Effects of acute and chronic morphine treatments on calcium localization and binding in brain. J Pharmacol Exp Ther (1978) 1.06
Brain reward deficits accompany naloxone-precipitated withdrawal from acute opioid dependence. Pharmacol Biochem Behav (2004) 1.06
Are NMDA receptors involved in opiate-induced neural and behavioral plasticity? A review of preclinical studies. Psychopharmacology (Berl) (2000) 1.05
Morphine: conditioned increases in self-administration in rhesus monkeys. Science (1969) 1.04
Quantitation of physical dependence in mice by naloxone-precipitated jumping after a single dose of morphine. Res Commun Chem Pathol Pharmacol (1975) 1.04
Conditioned suppression by a stimulus associated with nalorphine in morphine-dependent monkeys. J Exp Anal Behav (1967) 1.02
Acute tolerance associated with a single opiate administration: involvement of N-methyl-D-aspartate-dependent pain facilitatory systems. Neuroscience (1998) 1.02
A comparison of the effects of naloxone upon body weight loss and suppression of fixed-ratio operant behavior in morphine-dependent rats. J Pharmacol Exp Ther (1977) 1.01
Reinforcement processes in opiate addiction: a homeostatic model. Neurochem Res (1996) 1.01
Assessment of acute and chronic morphine dependence in male and female mice. Pharmacol Biochem Behav (2001) 1.01
Morphine and cocaine influence on CRF biosynthesis in the rat central nucleus of amygdala. Neuropeptides (2003) 0.99
In search of a new pharmacological treatment for drug and alcohol addiction: N-methyl-D-aspartate (NMDA) antagonists. Drug Alcohol Depend (2000) 0.99
Locomotor activity and antinociception after putative mu, kappa and sigma opioid receptor agonists in the rat: influence of dopaminergic agonists and antagonists. J Pharmacol Exp Ther (1981) 0.98
Opposing roles of the amygdala and dorsolateral periaqueductal gray in fear-potentiated startle. Neurosci Biobehav Rev (1997) 0.97
Elevated startle during withdrawal from acute morphine: a model of opiate withdrawal and anxiety. Psychopharmacology (Berl) (2003) 0.97
Acute physical dependence in man: effects of naloxone after brief morphine exposure. J Pharmacol Exp Ther (1988) 0.96
Naloxone-precipitated jumping activity in mice following the acute administration of morphine. Eur J Pharmacol (1974) 0.96
Differential expression of response-disruptive and somatic indices of opiate withdrawal during the initiation and development of opiate dependence. Behav Pharmacol (1999) 0.96
Naloxone for antagonism of morphine-induced respiratory depression. Anesth Analg (1973) 0.95
Inhibition by naloxone of tolerance and dependence in mice treated acutely and chronically with morphine. Res Commun Chem Pathol Pharmacol (1977) 0.94
Conditioned place aversion to the "hangover" phase of acute ethanol administration in the rat. Alcohol (2000) 0.94
Changes in urination/defecation, auditory startle response, and startle-induced ultrasonic vocalizations in rats undergoing morphine withdrawal: similarities and differences between acute and chronic dependence. J Pharmacol Exp Ther (2003) 0.94
Acute opioid physical dependence in postaddict humans: naloxone dose effects after brief morphine exposure. J Pharmacol Exp Ther (1989) 0.93
Total neurochemical lesion of noradrenergic neurons of the locus ceruleus does not alter either naloxone-precipitated or spontaneous opiate withdrawal nor does it influence ability of clonidine to reverse opiate withdrawal. J Pharmacol Exp Ther (1999) 0.93
Pharmacologic characterization of the sensitization to the rate-decreasing effects of naltrexone induced by acute opioid pretreatment in rats. J Pharmacol Exp Ther (1990) 0.93
Repeated experience with naloxone facilitates acute morphine withdrawal: potential role for conditioning processes in acute opioid dependence. Pharmacol Biochem Behav (2003) 0.93
Acute tolerance to spinally administered morphine compares mechanistically with chronically induced morphine tolerance. J Pharmacol Exp Ther (1997) 0.93
Opiate withdrawal signs precipitated by naloxone following a single exposure to morphine: potentiation with a second morphine exposure. Psychopharmacology (Berl) (1997) 0.92
Calcium-dependent mechanisms involved in presynaptic long-term depression at the hippocampal mossy fibre-CA3 synapse. Eur J Neurosci (1999) 0.92
Intracranial self-stimulation in rats: sensitization to an opioid antagonist following acute or chronic treatment with mu opioid agonists. J Pharmacol Exp Ther (1997) 0.91
The aversive properties of acute morphine dependence persist 48 h after a single exposure to morphine: evaluation by taste and place conditioning. Pharmacol Biochem Behav (2002) 0.91
DPDPE-UK14,304 synergy is retained in mu opioid receptor knockout mice. Pain (2003) 0.91
Involvement of delta 2 opioid receptors in the development of morphine dependence in mice. J Pharmacol Exp Ther (1993) 0.90
Effects of peripheral and central administration of calcium channel blockers in the naloxone-precipitated abstinence syndrome in morphine-dependent rats. Eur J Pharmacol (1987) 0.89
Role of spinal mu opioid receptors in the development of morphine tolerance and dependence. J Pharmacol Exp Ther (1984) 0.89
Conditioned sucrose aversions produced by naloxone-precipitated withdrawal from acutely administered morphine. Pharmacol Biochem Behav (1997) 0.89
Opioid physical dependence development: effects of single versus repeated morphine pretreatments and of subjects' opioid exposure history. Psychopharmacology (Berl) (1994) 0.89
The effects of LY293558, an AMPA receptor antagonist, on acute and chronic morphine dependence. Brain Res (1997) 0.88
Naloxone-precipitated morphine withdrawal induced place aversions: effect of naloxone at 24 hours postmorphine. Pharmacol Biochem Behav (1998) 0.87
Changes in response rates and reinforcement thresholds for intracranial self-stimulation during morphine withdrawal. Pharmacol Biochem Behav (1986) 0.87
Further studies on the acute dependence produced by morphine in opiate naive rats. Life Sci (1982) 0.86
Properties of LTD and LTP of retinocollicular synaptic transmission in the developing rat superior colliculus. Eur J Neurosci (2002) 0.86
Mianserin attenuates naloxone-precipitated withdrawal signs in rats acutely or chronically dependent upon morphine. J Pharmacol Exp Ther (1986) 0.85
Antagonist-precipitated opioid withdrawal in rats: evidence for dissociations between physical and motivational signs. Pharmacol Biochem Behav (1994) 0.85
Acute opioid physical dependence in humans: effect of varying the morphine-naloxone interval. I. J Pharmacol Exp Ther (1989) 0.85
Tolerance and dependence after continuous morphine infusion from osmotic pumps measured by operant responding in rats. Psychopharmacology (Berl) (1990) 0.85
Opiate dependence following acute injections of morphine and naloxone: the assessment of various withdrawal signs. Pharmacol Biochem Behav (1981) 0.85
Ultrasounds during morphine withdrawal in rats. Psychopharmacology (Berl) (1991) 0.85
Plasma corticosterone changes in response to central or peripheral administration of kappa and sigma opiate agonists. J Pharmacol Exp Ther (1985) 0.84
A COMPARISON BETWEEN ACUTE AND CHRONIC PHYSICAL DEPENDENCE IN THE CHRONIC SPINAL DOG. J Pharmacol Exp Ther (1964) 0.84
Is the motivational effect of opiate withdrawal reflected by common somatic indices of precipitated withdrawal? A place conditioning study in the rat. Brain Res (1987) 0.84
Elevated startle during withdrawal from acute morphine: a model of opiate withdrawal and anxiety. Psychopharmacology (Berl) (2003) 0.97
Dissociable effects of hippocampus lesions on expression of fear and trace fear conditioning memories in rats. Hippocampus (2006) 0.97
The nucleus accumbens is not critically involved in mediating the effects of a safety signal on behavior. Neuropsychopharmacology (2005) 0.96
Timing of fear expression in trace and delay conditioning measured by fear-potentiated startle in rats. Learn Mem (2004) 0.95
Reduced emotional signs of opiate withdrawal in rats selectively bred for low (LoS) versus high (HiS) saccharin intake. Psychopharmacology (Berl) (2012) 0.93
Canonical TGF-beta signaling is required for the balance of excitatory/inhibitory transmission within the hippocampus and prepulse inhibition of acoustic startle. J Neurosci (2010) 0.92
Distinct profiles of anxiety and dysphoria during spontaneous withdrawal from acute morphine exposure. Neuropsychopharmacology (2009) 0.92
Iron deficiency with or without anemia impairs prepulse inhibition of the startle reflex. Hippocampus (2013) 0.89
An anatomical basis for opponent process mechanisms of opiate withdrawal. J Neurosci (2011) 0.89
Effects of the NMDA receptor antagonist memantine on the expression and development of acute opiate dependence as assessed by withdrawal-potentiated startle and hyperalgesia. Psychopharmacology (Berl) (2007) 0.88
Potentiated startle as a measure of the negative affective consequences of repeated exposure to nicotine in rats. Psychopharmacology (Berl) (2009) 0.87
Increased dopamine receptor activity in the nucleus accumbens shell ameliorates anxiety during drug withdrawal. Neuropsychopharmacology (2012) 0.87
Episodic withdrawal promotes psychomotor sensitization to morphine. Neuropsychopharmacology (2010) 0.87
Hippocampal activity, but not plasticity, is required for early consolidation of fear conditioning with a short trace interval. Eur J Neurosci (2007) 0.85
Emotional reactivity to emotional and smoking cues during smoking abstinence: potentiated startle and P300 suppression. Psychophysiology (2011) 0.85
Multigenerational effects of fetal-neonatal iron deficiency on hippocampal BDNF signaling. Physiol Rep (2013) 0.83
HPA axis dysregulation following prenatal opiate exposure and postnatal withdrawal. Neurotoxicol Teratol (2005) 0.83
Potentiated startle and hyperalgesia during withdrawal from acute morphine: effects of multiple opiate exposures. Psychopharmacology (Berl) (2004) 0.82
Protracted manifestations of acute dependence after a single morphine exposure. Psychopharmacology (Berl) (2011) 0.79
Effects of chronic hypoxia in developing rats on dendritic morphology of the CA1 subarea of the hippocampus and on fear-potentiated startle. Brain Res (2007) 0.79
Role of corticosterone in trace and delay conditioned fear-potentiated startle in rats. Behav Neurosci (2010) 0.78
Affective and neuroendocrine effects of withdrawal from chronic, long-acting opiate administration. Brain Res (2013) 0.77
Effects of age, but not sex, on elevated startle during withdrawal from acute morphine in adolescent and adult rats. Behav Pharmacol (2015) 0.76
Recurrent Moderate Hypoglycemia Suppresses Brain-Derived Neurotrophic Factor Expression in the Prefrontal Cortex and Impairs Sensorimotor Gating in the Posthypoglycemic Period in Young Rats. Dev Neurosci (2016) 0.75